PDTM-05. CD271 (p75NTR) AS A NOVEL DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR SHH MEDULLOBLASTOMA

The extensive heterogeneity within the medulloblastoma (MB) molecular variants has revealed a critical need for subtype-specific biomarkers and therapeutic strategies. Using a high throughput flow cytometry screen and gain/loss of function studies, we previously identified CD271/p75NTR as a candidat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Liang, Lisa, Morrison, Ludivine, Tatari, Nazanin, Ramaswamy, Vijay, Bigio, Marc Del, Taylor, Michael, Hawkins, Cynthia, Chan, Jennifer A, Werbowetski-Ogilvie, Tamra
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692373/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.770
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares